Senior insider sale
Business Development Director at NEUROONE MEDICAL TECHNOLOGIES CORP — senior position signals high conviction
$55.9K
39.40K shares
What this filing means
CHRISTIANSON MARK plans to sell 39.40K shares of NEUROONE MEDICAL TECHNOLOGIES CORP valued at approximately $55.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001973097-26-000019
Officer· Business Development Director
Since Feb 2026
39.40K
Shares to sell
$55.9K
Approx. market value
30.69K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Awarded
N/A
4/20/2026
30.69KTotal acquired30.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/20/2026 | Awarded N/A | 30.69K | — |
| Total | 30.69K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
15.36K
Market value
$11.1K
3/30/2026
—Completed
Units to sell
100.00
Market value
$78.00
3/13/2026
—Completed
Units to sell
217.00
Market value
$637.26
3/12/2026
—Completed
Units to sell
2.11K
Market value
$1.6K
3/11/2026
—Completed
Units to sell
11.61K
Market value
$9.1K
3/10/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$33.4K
6/30/2026
Total
Units
39.40K
Value
$55.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/30/2026 | 15.36K | $11.1K | — | Completed |
3/13/2026 | 100.00 | $78.00 | — | Completed |
3/12/2026 | 217.00 | $637.26 | — | Completed |
3/11/2026 | 2.11K | $1.6K | — | Completed |
3/10/2026 | 11.61K | $9.1K | — | Completed |
| Planned — Approximate Date | ||||
6/30/2026 | 10K | $33.4K | NASDAQ | Planned |
| Total | 39.40K | $55.9K | ||